核治療薬の世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)

GlobalInfoResearchが発行した調査報告書(GIR9075913)
◆英語タイトル:Global Therapeutic Nuclear Medicines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
◆商品コード:GIR9075913
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2019年6月(※2024年版があります。お問い合わせください。)
◆ページ数:122
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、核治療薬の世界市場について調べ、まとめました。種類別セグメントは、ラジウム-223、ルテチウム-177、ヨウ素-131、その他等、用途別セグメントは、甲状腺、骨転移、リンパ腫、その他等に区分しました。核治療薬の世界市場概観、企業動向、企業別核治療薬シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・核治療薬の市場概観
・核治療薬の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・核治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・核治療薬の世界市場規模
・核治療薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・核治療薬のアメリカ市場規模推移
・核治療薬のカナダ市場規模推移
・核治療薬のメキシコ市場規模推移
・核治療薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・核治療薬のドイツ市場規模推移
・核治療薬のイギリス市場規模推移
・核治療薬のロシア市場規模推移
・核治療薬のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・核治療薬の日本市場規模推移
・核治療薬の中国市場規模推移
・核治療薬の韓国市場規模推移
・核治療薬のインド市場規模推移
・核治療薬の東南アジア市場規模推移
・核治療薬の南米市場分析(ブラジル、アルゼンチン等)
・核治療薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・核治療薬の種類別分析/販売量、売上、市場シェア(ラジウム-223、ルテチウム-177、ヨウ素-131、その他)
・核治療薬の用途別分析/市場規模(甲状腺、骨転移、リンパ腫、その他)
・核治療薬の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・核治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Scope of the Report:
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.
The worldwide market for Therapeutic Nuclear Medicines is expected to grow at a CAGR of roughly 17.2% over the next five years, will reach 1947.5 million US$ in 2024, from 879.8 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Therapeutic Nuclear Medicines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Radium-223
Lutetium-177
Iodine-131
Other

Market Segment by Applications, can be divided into
Thyroid
Bone Metastasis
Lymphoma
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines in 2017 and 2018.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Therapeutic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Radium-223
1.2.2 Lutetium-177
1.2.3 Iodine-131
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Thyroid
1.3.2 Bone Metastasis
1.3.3 Lymphoma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Therapeutic Nuclear Medicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Therapeutic Nuclear Medicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 China Isotope & Radiation
2.3.1 Business Overview
2.3.2 Therapeutic Nuclear Medicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Dongcheng
2.4.1 Business Overview
2.4.2 Therapeutic Nuclear Medicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Q BioMed
2.5.1 Business Overview
2.5.2 Therapeutic Nuclear Medicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Curium Pharmaceuticals
2.6.1 Business Overview
2.6.2 Therapeutic Nuclear Medicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Jubilant DraxImage
2.7.1 Business Overview
2.7.2 Therapeutic Nuclear Medicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Lantheus
2.8.1 Business Overview
2.8.2 Therapeutic Nuclear Medicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Spectrum Pharmaceuticals
2.9.1 Business Overview
2.9.2 Therapeutic Nuclear Medicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Progenics Pharmaceuticals
2.10.1 Business Overview
2.10.2 Therapeutic Nuclear Medicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 International Isotopes
2.11.1 Business Overview
2.11.2 Therapeutic Nuclear Medicines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Therapeutic Nuclear Medicines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share in 2018
3.3.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Therapeutic Nuclear Medicines Market Analysis by Regions
4.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Regions
4.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Regions (2014-2019)
4.2 North America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.3 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.5 South America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5 North America Therapeutic Nuclear Medicines by Country
5.1 North America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
5.1.1 North America Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
5.1.2 North America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
5.2 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5.3 Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5.4 Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6 Europe Therapeutic Nuclear Medicines by Country
6.1 Europe Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
6.1.1 Europe Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
6.2 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.3 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.4 France Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.5 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.6 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Therapeutic Nuclear Medicines by Country
7.1 Asia-Pacific Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
7.2 China Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.3 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.4 Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.5 India Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8 South America Therapeutic Nuclear Medicines by Country
8.1 South America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
8.1.1 South America Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
8.1.2 South America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8.3 Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8.4 Colombia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Therapeutic Nuclear Medicines by Countries
9.1 Middle East and Africa Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.3 Turkey Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.4 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.5 Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.6 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
10 Global Therapeutic Nuclear Medicines Market Segment by Type
10.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2014-2019)
10.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
10.2 Radium-223 Sales Growth and Price
10.2.1 Global Radium-223 Sales Growth (2014-2019)
10.2.2 Global Radium-223 Price (2014-2019)
10.3 Lutetium-177 Sales Growth and Price
10.3.1 Global Lutetium-177 Sales Growth (2014-2019)
10.3.2 Global Lutetium-177 Price (2014-2019)
10.4 Iodine-131 Sales Growth and Price
10.4.1 Global Iodine-131 Sales Growth (2014-2019)
10.4.2 Global Iodine-131 Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global Therapeutic Nuclear Medicines Market Segment by Application
11.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
11.2 Thyroid Sales Growth (2014-2019)
11.3 Bone Metastasis Sales Growth (2014-2019)
11.4 Lymphoma Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate (2019-2024)
12.2 Therapeutic Nuclear Medicines Market Forecast by Regions (2019-2024)
12.2.1 North America Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.2 Europe Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.4 South America Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.3 Therapeutic Nuclear Medicines Market Forecast by Type (2019-2024)
12.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2019-2024)
12.3.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2019-2024)
12.4 Therapeutic Nuclear Medicines Market Forecast by Application (2019-2024)
12.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2019-2024)
12.4.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 核治療薬の世界市場:企業別、地域別、種類別、用途別、市場予測(~2024)(Global Therapeutic Nuclear Medicines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。